Comparative Analysis of Red Blood Cells, White Blood Cells, Platelet Count, and Indices in Type 2 Diabetes Mellitus Patients and Normal Controls: Association and Clinical Implications

References

• IDF. Diabetes Atlas. 10th ed. Brussels, Belgium: IDF Diabetes Atlas; 2021.
   Google Scholar
• Sobczak AIS, Stewart AJ. Coagulatory defects in type-1 and type-2 diabetes. Int J Mol Sci. 2019;20(24):6345. doi:10.3390/ijms20246345
   PubMed Web of Science ®Google Scholar
• Twig G, Afek A, Shamiss A, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care. 2013;36(2):276–282. doi:10.2337/dc11-2298
   PubMed Web of Science ®Google Scholar
• Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications. 2009;23(2):89–94. doi:10.1016/j.jdiacomp.2008.01.006
   PubMed Web of Science ®Google Scholar
• Ezenwaka CE, Jones-Lecointe A, Nwagbara E, Seales D, Okali F. Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 2008;7(1):25. doi:10.1186/1475-2840-7-25
   PubMedGoogle Scholar
• Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol. 2008;2(6):1130–1138. doi:10.1177/193229680800200622
   PubMedGoogle Scholar
• Ziaee A, Ghorbani A, Kalbasi S, Hejrati A, Moradi S. Association of hematological indices with prediabetes: a cross-sectional study. Electron Physician. 2017;9(9):5206–5211. doi:10.19082/5206
   PubMedGoogle Scholar
• Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91–99. doi:10.2147/DMSO.S97563
   PubMed Web of Science ®Google Scholar
• Ebrahim H, Fiseha T, Ebrahim Y, Bisetegn H, Akash MSH. Comparison of hematological parameters between type 2 diabetes mellitus patients and healthy controls at Dessie comprehensive specialized hospital, Northeast Ethiopia: comparative cross-sectional study. PLoS One. 2022;17(7):e0272145. doi:10.1371/journal.pone.0272145
   PubMedGoogle Scholar
• Hamali HA, Saboor M, Dobie G, et al. Procoagulant microvesicles in COVID-19 patients: possible modulators of inflammation and prothrombotic tendency. Infect Drug Resist. 2022;15:2359–2368. doi:10.2147/IDR.S355395
   PubMed Web of Science ®Google Scholar
• Zhong Q, Peng J. Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID-19. J Clin Lab Anal. 2021;35(1):e23607. doi:10.1002/jcla.23607
   PubMed Web of Science ®Google Scholar
• Sayed AA, Allam AA, Sayed AI, Alraey MA, Joseph MV. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia. Saudi Med J. 2021;42(4):370 LP–376 . doi:10.15537/smj.2021.42.4.20200818
   Web of Science ®Google Scholar
• Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2015;8:525–533. doi:10.2147/DMSO.S85318
   PubMed Web of Science ®Google Scholar
• Arkew M, Yemane T, Mengistu Y, Gemechu K, Tesfaye G, Johnson C. Hematological parameters of type 2 diabetic adult patients at debre berhan referral hospital, Northeast Ethiopia: a comparative cross-sectional study. PLoS One. 2021;16(6):e0253286. doi:10.1371/journal.pone.0253286
   PubMed Web of Science ®Google Scholar
• Wang Z-S, Song Z-C, Bai J-H, et al. Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus. Vasc Health Risk Manag. 2013;9:237–243. doi:10.2147/VHRM.S43211
   PubMedGoogle Scholar
• Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63(4):1499–1507. doi:10.1046/j.1523-1755.2003.00885.x
   PubMed Web of Science ®Google Scholar
• Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease? Nat Clin Pract Nephrol. 2007;3(1):20–30. doi:10.1038/ncpneph0378
   PubMedGoogle Scholar
• Hamali HA, Saboor M. Undiagnosed hemoglobinopathies: a potential threat to the premarital screening program. Pakistan J Med Sci. 2019;35(6):1611–1615. doi:10.12669/pjms.35.6.976
   PubMed Web of Science ®Google Scholar
• Hamali HA, Mobarki AA, Saboor M, et al. Prevalence of anemia among Jazan University students. Int J Gen Med. 2020;13:765–770. doi:10.2147/IJGM.S275702
   PubMed Web of Science ®Google Scholar
• Vlagopoulos PT, Tighiouart H, Weiner DE, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005;16(11):3403–3410. doi:10.1681/ASN.2005030226
   PubMed Web of Science ®Google Scholar
• Pan J, Borné Y, Engström G. The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population. Sci Rep. 2019;9(1):16208. doi:10.1038/s41598-019-52708-2
   PubMedGoogle Scholar
• Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–1606. doi:10.4314/ahs.v19i1.35
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52(7):1799–1805. doi:10.2337/diabetes.52.7.1799
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–334. doi:10.1001/jama.286.3.327
   PubMed Web of Science ®Google Scholar
• Fujita T, Hemmi S, Kajiwara M, et al. Complement-mediated chronic inflammation is associated with diabetic microvascular complication. Diabetes Metab Res Rev. 2013;29(3):220–226. doi:10.1002/dmrr.2380
   PubMed Web of Science ®Google Scholar
• Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–488. doi:10.4149/BLL_2021_078
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Fang S, et al. Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:6219545. doi:10.1155/2020/6219545
   PubMed Web of Science ®Google Scholar
• Mobarki AA, Dobie G, Saboor M, et al. MPR and NLR as prognostic markers in ICU-admitted patients with COVID-19 in Jazan, Saudi Arabia. Infect Drug Resist. 2021;14:4859–4864. doi:10.2147/IDR.S342259
   PubMed Web of Science ®Google Scholar
• Sefil F, Ulutas KT, Dokuyucu R, et al. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581–588. doi:10.1177/0300060513516944
   PubMed Web of Science ®Google Scholar
• Hamali HA. The mighty role of platelets in immunity, inflammation, cancer and angiogenesis. Majmaah J Heal Sci. 2020;8(1):65–81. doi:10.5455/mjhs.2020.01.008
   Google Scholar
• Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care. 2009;32(4):525–527. doi:10.2337/dc08-1865
   PubMed Web of Science ®Google Scholar
• Jindal S, Gupta S, Gupta R, et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011;16(2):86–89. doi:10.1179/102453311X12902908412110
   PubMed Web of Science ®Google Scholar
• Ebrahim H, Asrie F, Getaneh Z. Basic coagulation profiles and platelet parameters among adult type 1 and type 2 diabetes patients at Dessie Referral Hospital, Northeast Ethiopia: comparative cross-sectional study. J Blood Med. 2021;12:33–42. doi:10.2147/JBM.S287136
   PubMed Web of Science ®Google Scholar
• Kodiatte TA, Manikyam UK, Rao SB, et al. Mean platelet volume in Type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5–9. doi:10.4103/0974-2727.98662
   PubMedGoogle Scholar
• Sterner G, Carlson J, Ekberg G. Raised platelet levels in diabetes mellitus complicated with nephropathy. J Intern Med. 1998;244(6):437–441. doi:10.1111/j.1365-2796.1998.00349.x
   PubMed Web of Science ®Google Scholar
• Hekimsoy Z, Payzin B, Örnek T, Kandoğan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications. 2004;18(3):173–176. doi:10.1016/S1056-8727(02)00282-9
   PubMed Web of Science ®Google Scholar
• Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol. 2006;59(2):146–149. doi:10.1136/jcp.2004.025387
   PubMed Web of Science ®Google Scholar
• Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15(8):475–478. doi:10.1080/0953710042000267707
   PubMed Web of Science ®Google Scholar